Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> od Pauline Krijgsheld (1973917)

Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> od Pauline Krijgsheld (1973917)

Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> od Pauline Krijgsheld (1973917)

Data Sheet 2_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf od Jane K. O’Hara (8828342)

Hasła przedmiotowe:

Data Sheet 3_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf od Jane K. O’Hara (8828342)

Hasła przedmiotowe:

Data Sheet 1_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf od Jane K. O’Hara (8828342)

Hasła przedmiotowe:

Time to self-harm event after admission during most recent incarceration. od Hygiea Casiano (2189752)

Demographic correlates of self-harm while in youth custody during most recent incarceration. od Hygiea Casiano (2189752)

Examples of terms used in the academic literature to describe practice encounters not involving in-person contact. od Kathleen Leslie (15374710)

Reasons and patterns of self-harm patients. od Willie Njoroge (20623714)

Hasła przedmiotowe:

Self-harm patients’ spiritual history. od Willie Njoroge (20623714)

Hasła przedmiotowe:

Compartmentalization as tobacco industry tactic to distract from health harms of cigarettes [57]. od Yogi Hale Hendlin (5158895)

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity-6 od Denise A Gonzales (38545)

“…The RR of CIN would have to be less than 0.67 in order for the RR of hemodialysis not to be on the side of harm (RR < 1).…”

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. od Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. od Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. od Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. od Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. od Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. od Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. od Diana M. Hendrickx (1507435)